IGTR vs. PPH ETF Comparison

Comparison of Innovator Gradient Tactical Rotation Strategy ETF (IGTR) to Market Vectors Pharmaceutical ETF (PPH)
IGTR

Innovator Gradient Tactical Rotation Strategy ETF

IGTR Description

Innovator Gradient Tactical Rotation Strategy ETF is an exchange traded fund launched and managed by Innovator Capital Management, LLC. The fund is co-managed by Gradient Investments, LLC and Penserra Capital Management LLC. The fund invests in the public equity markets of global region. The fund invests in stocks of companies operating across diversified sectors. The fund invests in momentum and volatile stocks of companies across diversified market capitalization. It employs fundamental analysis with top-down stock picking approach to create its portfolio. Innovator Gradient Tactical Rotation Strategy ETF is domiciled in United States.

Grade (RS Rating)

Last Trade

$28.14

Average Daily Volume

13,143

Number of Holdings *

3

* may have additional holdings in another (foreign) market
PPH

Market Vectors Pharmaceutical ETF

PPH Description The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Grade (RS Rating)

Last Trade

$94.54

Average Daily Volume

148,493

Number of Holdings *

23

* may have additional holdings in another (foreign) market
Performance
Period IGTR PPH
30 Days -1.69% -4.51%
60 Days 8.33% 0.82%
90 Days 0.71% 4.81%
12 Months 29.66% 21.13%
1 Overlapping Holdings
Symbol Grade Weight in IGTR Weight in PPH Overlap
NVO F 8.81% 8.63% 8.63%
Compare ETFs